Superparamagnetic nanoparticle capture of prions for amplification

Journal of Virology

Volumn 85, Issue 6, 2011, Pages 2813-2817

  Miller, Michael B ^a   Supattapone, Surachai ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; PRION PROTEIN ANTIBODY; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; HAMSTER; IMMUNOPRECIPITATION; MAGNETISM; NANOTECHNOLOGY; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; VIRUS DETECTION; VIRUS STRAIN;

ANIMALS; CRICETINAE; MAGNETITE NANOPARTICLES; MICE; PRIONS; SENSITIVITY AND SPECIFICITY; VIROLOGY;

EID: 79952395339     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02451-10     Document Type: Article

References (29)

1. Atarashi, R., et al. 2007. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Methods 4:645-650. (Pubitemid 47202476)
2. Brown, D. R., et al. 1997. The cellular prion protein binds copper in vivo. Nature 390:684-687. (Pubitemid 28016355)
3. Bruce, M., et al. 1994. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 343:405-411.
4. Castilla, J., et al. 2008. Cell-free propagation of prion strains. EMBO J. 27:2557-2566.
5. Castilla, J., P. Saa, C. Hetz, and C. Soto. 2005. In vitro generation of infectious scrapie prions. Cell 121:195-206.
6. Castilla, J., et al. 2006. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol. 412:3-21. (Pubitemid 44548570)
7. Chen, B., R. Morales, M. A. Barria, and C. Soto. 2010. Estimating prion concentration in fluids and tissues by quantitative PMCA. Nat. Methods 7:519-520.
8. de Vries, I. J., et al. 2005. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 23:1407-1413.
9. Edgeworth, J. A., et al. 2010. Spontaneous generation of mammalian prions. Proc. Natl. Acad. Sci. U. S. A. 107:14402-14406.
10. Eiden, M., et al. 2010. Biochemical and immunohistochemical characterization of feline spongiform encephalopathy in a German captive cheetah. J. Gen. Virol. 91:2874-2883.
11. Fichet, G., et al. 2004. Novel methods for disinfection of prion-contaminated medical devices. Lancet 364:521-526. (Pubitemid 39070412)
12. Gregori, L., et al. 2006. Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins. Lancet 368:2226-2230. (Pubitemid 44959015)
13. Gregori, L., et al. 2004. Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet 364:529-531. (Pubitemid 39070414)
14. Johnson, C. J., et al. 2006. Prions adhere to soil minerals and remain infectious. PLoS Pathog. 2:e32.
15. Liu, X., et al. 2006. Preparation and characterization of hydrophobic superparamagnetic magnetite gel. J. Magnetism Magn. Mater. 306:248-253.
16. Luhr, K. M., P. Low, A. Taraboulos, T. Bergman, and K. Kristensson. 2009. Prion adsorption to stainless steel is promoted by nickel and molybdenum. J. Gen. Virol. 90:2821-2828.
17. Mathiason, C. K., et al. 2006. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 314:133-136. (Pubitemid 44547758)
18. Moroncini, G., et al. 2004. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc. Proc. Natl. Acad. Sci. U. S. A. 101:10404-10409.
19. Muller-Schiffmann, A., et al. 2009. Complementarity determining regions of an anti-prion protein scFv fragment orchestrate conformation specificity and antiprion activity. Mol. Immunol. 46:532-540.
20. Nagaoka, K., et al. 2010. Sensitive detection of scrapie prion protein in soil. Biochem. Biophys. Res. Commun. 397:626-630.
21. Norén, K., and M. Kempe. 2009. Multilayered magnetic nanoparticles as a support in solid-phase peptide synthesis. Int. J. Pept. Res. Ther. 15:287-292.
22. Paramithiotis, E., et al. 2003. A prion protein epitope selective for the pathologically misfolded conformation. Nat. Med. 9:893-899.
23. Peden, A. H., M. W. Head, D. L. Ritchie, J. E. Bell, and J. W. Ironside. 2004. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364:527-529.
24. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. U. S. A. 95:13363-13383.
25. Rees, H. C., B. C. Maddison, J. P. Owen, G. C. Whitelam, and K. C. Gough. 2009. Concentration of disease-associated prion protein with silicon dioxide. Mol. Biotechnol. 41:254-262.
26. Safar, J., et al. 1998. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4:1157-1165.
27. Saunders, S. E., J. C. Bartz, and S. L. Bartelt-Hunt. 2009. Prion protein adsorption to soil in a competitive matrix is slow and reduced. Environ. Sci. Technol. 43:7728-7733.
28. Tarcha, P. J., and T. E. Rohr. 2004. Diagnostics and Biomaterials, p. 687-688. In B. D. Ratner (ed.), Biomaterials science: an introduction to materials in medicine. Elsevier, London, United Kingdom.
29. Zobeley, E., E. Flechsig, A. Cozzio, M. Enari, and C. Weissmann. 1999. Infectivity of scrapie prions bound to a stainless steel surface. Mol. Med. 5:240-243.